Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-06

Clinical Trial Update: Adrenomedullin and Outcome in Severe Sepsis and Septic Shock

View source ↗

Summary

A completed clinical trial examined the relationship between adrenomedullin and outcomes in patients with sepsis and septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adrenomedullin (adrenomedullin)

Snippet

Sponsor: Sphingotec GmbH | Conditions: Severe Sepsis, Septic Shock | Status: COMPLETED